Glaukos Corporation (GKOS)

NYSE: GKOS · USD

$182

+0.47 (+0.3%)· Recorded snapshot

Market cap	10.7B
Revenue (ttm)	612.8M
Net income (ttm)	-188M
EPS (ttm)	-$3.25
Shares out	59M
P/E (forward)	1545.0x
Volume	1,418,252
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 612.8M
Net income (ttm): -188M
EPS (ttm): -$3.25
P/E (forward): 1545.0x
Market cap: 10.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E1,545

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-26

P25 n/aP50 n/aP75 n/a

ROIC-15.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GKOS indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001192448
Company name	Glaukos Corporation
Country	United States
Country code	US
CUSIP number	377322102
Earnings date	2026-10-28
Earnings time	amc
Employees	1,094
Employees change	99
Employees growth	9.95%
Enterprise value	$10.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2015-06-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US3773221029
Last 10-K release date	2026-02-23
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$10.7B
Market cap category	Large-Cap
Next earnings date	2027-02-16
Options	Yes
Price	$181.64
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	GKOS
U.S. state	California
Website	https://www.glaukos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.79%
EV/Sales	17.19x
FCF / EV yield	-0.12%
FCF yield	-0.11%
Forward EV/Sales	13.88x
Forward P/E	1,544.96x
Forward P/S	14.12x
Industry forward P/E	19.81x
Industry P/E	39.28x
P/B ratio	15.62x
P/S ratio	17.49x
Price / tangible book value	21.93x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-12.89%
EBITDA margin	-6.04%
Gross margin	79.12%
Operating margin	-12.89%
Pretax margin	-31.47%
Profit margin	-30.68%
Profit per employee	$-171,890
Revenue per employee	$560,182
ROA	-5.18%
ROA (5Y)	-6.05%
ROCE	-9.65%
ROE	-25.98%
ROE (5Y)	-20.6%
ROIC	-15.74%
ROIC (5Y)	-17.3%
SBC / revenue	13.09%
Tax / revenue	-0.78%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
FCF growth (Q)	108.36%
Gross profit growth	46.7%
Gross profit growth (Q)	55.92%
Gross profit growth 3Y	29.26%
Gross profit growth 5Y	17.38%
Net income growth quarters	1
Net income growth years	0
OCF growth (Q)	112.39%
Revenue growth	41.55%
Revenue growth (Q)	49.54%
Revenue growth (QoQ)	23.27%
Revenue growth 10Y	21.02%
Revenue growth 3Y	27.34%
Revenue growth 5Y	16.62%
Revenue growth quarters	14
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-11.2M
Depreciation and amortization	$42M
EBIT	$-79M
EBITDA	$-37M
EPS	$-3.25
FCF per share	$-0.21
Financing cash flow	$24.5M
Free cash flow	$-12.2M
Free cash flow minus SBC	$-92.4M
Gross profit	$484.9M
Income taxes	$-4.8M
Investing cash flow	$-14.7M
Net borrowing	$-1.2M
Net cash flow	$13M
Net income	$-188M
Operating cash flow minus SBC	$-81.2M
Operating income	$-79M
Revenue	$612.8M
Stock-based compensation	$80.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	14.94
Book value per share	$11.60
Debt / equity	0.16
Goodwill	$66.7M
Interest coverage	-16.1
Long-term assets	$404.7M
Long-term liabilities	$135.7M
Net cash (debt)	$178.6M
Net cash / market cap	1.67%
Net cash growth	6.68%
Net debt / equity	-0.26
Piotroski F-Score	3
Property, plant and equipment	$181.6M
Shareholders' equity	$682.5M
Tangible book value	$488.6M
Tangible book value per share	$8.30
Total assets	$920.5M
Total cash	$286.2M
Total debt	$107.6M
Total liabilities	$238M
WACC	8.03%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current assets	$515.8M
Current liabilities	$102.3M
Current ratio	5.04
Inventory turnover	2.07
Net working capital	$132M
Quick ratio	4.15
Working capital	$413.4M
Working capital turnover	1.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.22%
Dividend yield	0%
Shareholder yield	-3.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	438.99%
10Y return CAGR	18.35%
10Y total return	438.99%
150-day SMA	$149.14
1D price change	0.26%
1M price change	17.62%
1M total return	17.62%
1W price change	2.71%
1W total return	2.71%
1Y price change	140.01%
1Y return CAGR	140.16%
1Y total return	140.01%
20-day SMA	$169.87
200-day SMA	$140.13
3M price change	19.57%
3M total return	19.57%
3Y price change	169.3%
3Y return CAGR	39.12%
3Y total return	169.3%
50-day SMA	$171.18
50-day SMA vs 200-day SMA	50over200
52-week high	$191.62
52-week high date	2026-08-20
52-week low	$73.16
52-week low date	2025-10-28
5Y price change	324.59%
5Y return CAGR	33.54%
5Y total return	324.59%
6M price change	48.8%
6M total return	48.8%
All-time high	$191.62
All-time high date	2026-08-20
All-time low	$14.25
All-time low date	2016-02-08
Average true range (ATR)	$7.07
Average volume	1.1M
Beta (1Y)	0.41
Beta (2Y)	0.93
Beta (5Y)	0.7
Change from 52-week high	-5.21%
Change from 52-week low	148.28%
Change from all-time high	-5.21%
Change from all-time low	1,174.67%
Change from open	-0.2%
Day's gap	0.46%
Dollar volume	$257.6M
High price	$186.73
Low price	$177.25
Monthly RSI	63.97
Open price	$182.00
Position in 52-week range	46.31%
Premarket change	1.34%
Premarket close	$181.17
Premarket price	$183.60
Premarket volume	7.3K
Previous close	$181.17
Price vs 150-day SMA	21.79%
Price vs 20-day SMA	6.93%
Price vs 200-day SMA	29.63%
Price vs 50-day SMA	6.11%
Relative volume	1.36
RSI	64.95
Sharpe ratio	1.87
Sharpe ratio (3Y)	0.82
Sharpe ratio (5Y)	0.72
Sortino ratio	3.64
Sortino ratio (3Y)	1.43
Sortino ratio (5Y)	1.25
Volume	1.4M
Weekly RSI	64.13
YTD price change	60.87%
YTD total return	60.87%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56.8M
Float percentage	96.39%
Shares change (QoQ)	1.37%
Shares change (YoY)	3.22%
Shares held by insiders	3.57%
Shares held by institutions	104.18%
Shares outstanding	59M
Short % of float	6.78%
Short % of shares	6.53%
Short ratio	4.7 days

Deeper analysis on GKOS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GKOS report

Is a complete GKOS research report available?

No complete published report is available for Glaukos Corporation (GKOS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Glaukos Corporation (GKOS)

Price

Financial snapshot

Fair-value bridge

Latest news · GKOS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GKOS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GKOS

Frequently asked questions